MX2021010945A - Formula que enmascara el sabor para compuestos de cuerpos cetonicos. - Google Patents

Formula que enmascara el sabor para compuestos de cuerpos cetonicos.

Info

Publication number
MX2021010945A
MX2021010945A MX2021010945A MX2021010945A MX2021010945A MX 2021010945 A MX2021010945 A MX 2021010945A MX 2021010945 A MX2021010945 A MX 2021010945A MX 2021010945 A MX2021010945 A MX 2021010945A MX 2021010945 A MX2021010945 A MX 2021010945A
Authority
MX
Mexico
Prior art keywords
taste
compounds
masks
formula
ketone bodies
Prior art date
Application number
MX2021010945A
Other languages
English (en)
Spanish (es)
Inventor
Houston Smith
Bernadita P Desierto
Beverly Ann Schad
Danielle Lasota
Sean Whittemore
Original Assignee
Neuroenergy Ventures Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neuroenergy Ventures Inc filed Critical Neuroenergy Ventures Inc
Publication of MX2021010945A publication Critical patent/MX2021010945A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52Adding ingredients
    • A23L2/60Sweeteners
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/84Flavour masking or reducing agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/86Addition of bitterness inhibitors
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Seasonings (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Respiratory Apparatuses And Protective Means (AREA)
MX2021010945A 2019-03-14 2020-02-21 Formula que enmascara el sabor para compuestos de cuerpos cetonicos. MX2021010945A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962818208P 2019-03-14 2019-03-14
PCT/US2020/019174 WO2020185368A1 (en) 2019-03-14 2020-02-21 Taste-masking formulation for ketone body compounds

Publications (1)

Publication Number Publication Date
MX2021010945A true MX2021010945A (es) 2021-10-13

Family

ID=72426308

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021010945A MX2021010945A (es) 2019-03-14 2020-02-21 Formula que enmascara el sabor para compuestos de cuerpos cetonicos.

Country Status (11)

Country Link
US (1) US12225919B2 (https=)
EP (1) EP3937656B1 (https=)
JP (1) JP7287709B2 (https=)
KR (1) KR102865708B1 (https=)
CN (1) CN113543652B (https=)
BR (1) BR112021017954A2 (https=)
CA (1) CA3097783C (https=)
IL (1) IL278422B (https=)
MX (1) MX2021010945A (https=)
MY (1) MY204412A (https=)
WO (1) WO2020185368A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026003892A1 (en) 2024-06-28 2026-01-02 Dr. Schär S.P.A. Ketogenic food formulation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003342223A (ja) * 2002-05-30 2003-12-03 Kanebo Ltd 包接化合物およびこれを含有する組成物
US7851000B2 (en) * 2005-05-23 2010-12-14 Cadbury Adams Usa Llc Taste potentiator compositions and edible confectionery and chewing gum products containing same
US7807718B2 (en) 2006-06-30 2010-10-05 Sami A. Hashim Glyceride esters for the treatment of diseases associated with reduced neuronal metabolism of glucose
KR101558193B1 (ko) 2007-08-21 2015-10-12 세노믹스, 인코포레이티드 인간 t2r 쓴맛 수용체 및 이의 용도
AU2008355464C1 (en) * 2008-04-25 2014-11-20 Chiesi Farmaceutici S.P.A. Liquid formulation for deferiprone with palatable taste
GB201002983D0 (en) * 2010-02-22 2010-04-07 Tdeltas Ltd Nutritinal composition
BR112013031406B1 (pt) * 2011-06-08 2022-02-22 Lts Lohmann Therapie-Systeme Ag Tira de filme oral comestível e seu método de preparação
GB201206192D0 (en) * 2012-04-05 2012-05-23 Tdeltas Ltd Ketone bodies and ketone body esters and for maintaining or improving muscle power output
WO2015131001A1 (en) * 2014-02-27 2015-09-03 The Procter & Gamble Company Compositions with reduced bitter taste perception
US10292952B2 (en) * 2016-03-11 2019-05-21 Axcess Global Sciences, Llc Mixed salt compositions for maintaining or restoring electrolyte balance while producing elevated and sustained ketosis
US20160376263A1 (en) * 2016-07-26 2016-12-29 Senomyx, Inc. Bitter taste modifiers including substituted 1-benzyl-3-(1-(isoxazol-4-ylmethyl)-1h-pyrazol-4-yl)imidazolidine-2,4-diones and compositions thereof
US20180177753A1 (en) 2016-12-23 2018-06-28 Neuroenergy Ventures, Inc. Glyceryl 3-hydroxybutyrates for migraine symptom management
US20200222353A1 (en) 2019-01-14 2020-07-16 Christopher David Thompson Ketone ester and ketone salt compositions and methods for using the same

Also Published As

Publication number Publication date
CA3097783C (en) 2023-01-03
EP3937656A1 (en) 2022-01-19
MY204412A (en) 2024-08-27
EP3937656B1 (en) 2025-04-02
IL278422B (en) 2022-09-01
JP2022524152A (ja) 2022-04-27
US20220338510A2 (en) 2022-10-27
US12225919B2 (en) 2025-02-18
IL278422A (https=) 2020-12-31
CN113543652A (zh) 2021-10-22
WO2020185368A1 (en) 2020-09-17
EP3937656A4 (en) 2023-07-26
EP3937656C0 (en) 2025-04-02
US20220183327A1 (en) 2022-06-16
JP7287709B2 (ja) 2023-06-06
KR20210141991A (ko) 2021-11-23
CN113543652B (zh) 2024-07-05
KR102865708B1 (ko) 2025-09-26
BR112021017954A2 (pt) 2021-11-16
CA3097783A1 (en) 2020-09-17

Similar Documents

Publication Publication Date Title
CO2021005987A2 (es) Compuestos de anillo fusionado
CL2021000387A1 (es) Compuestos de anillo fusionado
UY37879A (es) Compuestos de bisamida que activan el sarcómero y sus usos
CL2019003154A1 (es) Proceso de preparación de un compuesto intermediario de fórmula (vi) para la preparación de compuestos de cannabidiol. (divisional solicitud 201800079)
UY38186A (es) Sal sódica de n-((1,2,3,5,6,7-hexahidro-s-indacen-4-il)carbamoil)-1-isopropil-1h-pirazol-3-sulfonamida
CL2018000198A1 (es) Composiciones de arni de transtiretina (ttr) y métodos para su uso para el tratamiento o prevencion de enfermedades asociadas con ttr
ECSP20035590A (es) Derivado de oxi-fluoropiperidina como inhibidor de quinasa
MX2017015277A (es) Derivado de pirido[3,4-d]pirimidina y sal farmaceuticamente aceptable de este.
ECSP20035222A (es) Derivado de amino-fluoropiperidina como inhibidor de quinasa
BR112018074621A2 (pt) derivados de pirazolopirimidina como inibidores de quinase
MX2020007947A (es) Inhibidores de erbb/btk.
BR112017019286A2 (pt) composto de fórmula (i) ou um sal farmaceuticamente aceitável deste
AR111304A1 (es) Métodos para sintetizar un inhibidor de mcl-1
CL2021002263A1 (es) Compuestos antibacterianos (solicitud divisional 202001147)
BR112017011316A2 (pt) derivados heterocíclicos e uso destes
CO2022001814A2 (es) Compuestos macrocíclicos como agonistas de sting y métodos y usos de los mismos
UY37941A (es) Derivados de bencimidazol y sus usos
MX2020003593A (es) Compuestos de benzotiazol y metodos para usar los mismos para tratar trastornos neurodegenerativos.
AR102981A1 (es) Inhibidores de la necrosis celular y métodos de preparación de los mismos
CO2021011023A2 (es) Compuesto heterocíclico, composición farmacéutica que lo comprende, método para su preparación, y uso de estos
CR20190236A (es) Compuestos terapéuticos y métodos para utilizarlos
MX2024007360A (es) Composiciones que comprenden compuestos de bisfluoroalquil-1,4-ben zodiacepinona y metodos de uso de las mismas.
BR112017005113A2 (pt) composto de fórmula geral (i), método para preparar um composto de fórmula geral (i), método para preparar um composto de fórmula geral (iv), composição farmacêutica para o tratamento de doenças relacionadas com atividades anormais de jak3 e/ou jak1 quinase, usos do composto, e usos da composição farmacêutica
CO2018001237A2 (es) Derivados de apramicina efectivos contra bacterias resistentes a múltiples fármacos y composiciones de los mismos
BR112017015744A2 (pt) composto apresentando uma estrutura de fórmula (i), um sal farmaceuticamente aceitável do mesmo ou um isômero ótico do mesmo, composição farmacêutica e uso do composto de fórmula (i) para o tratamento e prevenção de mycobacterium tuberculosis ou outras infecções microbianas